In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s “compassionate use” program—raising immediate questions if that sole patient is President Donald Trump, according to a report by Stat News.
Lilly’s retatrutide is a highly anticipated next-generation obesity drug that targets GIP and glucagon hormones in addition to GLP-1. It is currently in late-stage trials to treat obesity, diabetes, sleep apnea, and other conditions. Data from a Phase 3 trial that Lilly released in May indicates that patients with obesity (but without diabetes) who took the drug for 80 weeks lost 28 percent of their weight, an amount comparable to bariatric surgery.
Millions of Americans with obesity are eager to get the drug, with options being limited so far to enrolling in a clinical trial or trying to obtain it by dodgy methods.
But according to a barebones public notice and Stat’s sources, a single person has been granted early access through the expanded access, aka “compassionate use” pathway, which is typically used to grant access to patients with a “serious or immediately life-threatening disease or condition” and who are not able to enroll in a clinical trial, often because they are too ill.
The access request was first made in April, when the person was 79 years old (Trump turned 80 on June 14). It was made by a senior clinician at the National Institutes of Health named Ranganath Muniyappa, who requested it on behalf of a patient with refractory obesity, obstructive sleep apnea, and pulmonary hypertension, which is high blood pressure in the lungs. Sources told Stat this patient had spent a year on tirzepatide, a drug that targets the GLP-1 and GIP hormones. But the patient had achieved only moderate weight loss on the drug.
The patient’s name? John Baron
It would be extremely funny if he cheated his way to early entry, and then it turns out it isn’t safe for old fucks. Like maybe that hasn’t been tested since it’s still early enough in trials.
Until we find out that one of the side effects is violent psychotic dementia
one of the side effects is violent psychotic dementia
It’s not a side effect if the patient already suffers from it…
Has he tried copious amounts of injected bleach? Everybody says it works wonders.
There’s a new medical procedure that needs to be done only once. Kinetic injection of lead to the brain. So simple it can be self administered, or with the help of a friend in line of sight.
I’ve got three family members taking this drug and have both lost a ton of weight. All of them have lost sunstantial amounts of weight. My brother is down 70 pounds.
Ain’t no way Trump is taking it. He’s still fat as shit.
The drug works by killing your appetite. Trump’s a long-time abuser of amphetamines, which do the same thing. His current obesity means a reduction in appetite did nothing for him, which is probably why the previous anti-obesity drugs also failed.
It’s probably not him: he’s still a lardass.
That’s the point, apparently he tried other weight loss drugs and they didn’t work. I guess his addiction to McDonald’s is stronger than Ozempic.
Yeah there’s a class of folks who have psychological issues around food and so they won’t lower their eating when their hunger goes down. Which can be a real fucker since GP1s affect transit time and digestion, this might explain some of his pants pooping.
i thought it was from the decades of drug abuse
And that he’s fucking 80
Stat reporter Lizzy Lawrence replied, saying, “I asked you, the FDA, and HHS multiple times yesterday whether this application was for the President. No one answered my question directly.” Desai then seemed to confirm that no one had answered the question, calling it an “idiotic question.”
I’m gonna have to agree with Desai here. It’s a stupid fucking question. As much as I hate the guy, the only link is a 79 year old. This is national enquirer level of reporting.
I would point out that it wasn’t just the age. It that, but also things like very few people on the planet knew this drug was being researched at Eli Lily. When you look at the pool of people that could have had access to that knowledge, fit the age, weight, and description of other symptoms, it becomes a little easier to guess.
The very few people on the planet who have access to their annual statement?
This isn’t skunk works.
“Only people in the know would be able to find this [notice], using the drug name,” Richard Klein, who helped launch the FDA’s expanded access program in the 1980s, told Stat. “There is something very wrong with the way this is listed because no one would know what it is from the listing, or what it’s for.”
“Find this [notice]”. The notice that it was used for compassionate use. Not that the drug is being researched.
Form 10-K for the fiscal year ended December 31, 2022
Page 39. Publicly filed 3 years ago, in plain text the indication, molecule, and trial phase.
No, the only links are “79 years old,” “name not given,” and “literally the only person in the country who was approved for this”
That doesn’t strike you as “Hmm, maybe we should see if the fat-assed President is once again abusing his office for personal gain?”
“Name not given” applies to every person alive, and “only one person” also applies to everyone alive. Therefore the only link to Trump is “79-year old”, and I suppose “obese”, but the nature of the treatment and approval says to me that it rules him out instead of includes him.
As far as investigating abusing his office for personal gain, this is like saying Dahmer is murderer because he stepped on a bug. Maybe investigate the bodies instead.
Congrats; you aren’t curious enough to solve a fucking Scooby Doo mystery.
Why on earth you would (a) continue telling people that and then (b) insist that it makes you look like anything other than a pedantic dumbfuck is beyond explanation.
